(Q39984474)

16 September 2017

1 reference

title

Pharmaceutical Applications of Polymorphism (English)

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

16 March 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4899118

16 March 2023

Therapeutic Equivalency

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4899118

16 March 2023

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

16 March 2023

author name string

J. Haleblian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4899118

16 March 2023

W. McCrone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4899118

16 March 2023

language of work or name

English

0 references

publication date

1 August 1969

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:S0022354915369562?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

https://api.elsevier.com/content/article/PII:S0022354915369562?httpAccept=text/plain

16 March 2023

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Journal of Pharmaceutical Sciences

16 March 2023

published in

1 reference

16 September 2017

volume

58

1 reference

16 September 2017

issue

8

1 reference

16 September 2017

page(s)

911-929

1 reference

Annales de chimie et de physique

16 September 2017

cites work

1

19

350

Mitscherlich

1822

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

INFRARED IDENTIFICATION OF PHARMACEUTICALLY IMPORTANT STEROIDS WITH PARTICULAR REFERENCE TO THE OCCURENCE OF POLYMORPHISM

16 March 2023

17

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Infrared identification of barbiturates with particular reference to the occurrence of polymorphism.

16 March 2023

19

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

The polymorphism of phenobarbitone

16 March 2023

20

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Infrared identification of pharmaceutically important sulphonamides with particular reference to the occurrence of polymorphism.

16 March 2023

21

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

The status and future of chemical microscopy

16 March 2023

22

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Polymorphism and drug availability. II. Dissolution rate behavior of the polymorphic forms of sulfathiazole and methylprednisolone

16 March 2023

28

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate

16 March 2023

30

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Loss of sensitivity in distinguishing renal differences in dissolution rates due to increasing intensity of agitation

16 March 2023

35

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Comparative dissolution rates of weak acids and their sodium salts

16 March 2023

37

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Comparison of dissolution and absorption rates of different commercial aspirin tablets

16 March 2023

43

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Aspirin: dissolution rates of two polymorphic forms

16 March 2023

44

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

X-ray and crystallographic applications in pharmaceutical research. III. Crystal habit quantitation

16 March 2023

45

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

SOME CRYSTALLINE MODIFICATIONS OF THE TERT-BUTYLACETATES OF PREDNISOLONE AND HYDROCORTISONE

16 March 2023

49

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

16 March 2023

Crystallography. II

50

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Some physical and crystallographic properties of the ouabain hydrates

16 March 2023

51

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Polymorphism of cephaloridine.

16 March 2023

55

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Polymorphism and drug availability. Solubility relationships in the methylprednisolone system

16 March 2023

56

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

Heats of Transition of Methylprednisolone and Sulfathiazole by a Differential Thermal Analysis Method

16 March 2023

61

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

A dilatometric study of melting behaviors of some fats, waxes, and related substances of pharmaceutical importance. I. Polyethylene glycols, spermaceti, cetyl alcohol, petrolatum, white wax, and theobroma oil

16 March 2023

62

1 reference

https://api.crossref.org/works/10.1002/JPS.2600580802

16 March 2023

Identifiers

1 reference

16 September 2017

1 reference